California Healthcare Provider Expands Use of Knightscope Robots

MOUNTAIN VIEW, Calif., August 21, 2024–. [Nasdaq:KSCP] (“Knightscope” or the “Company”), an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety, today announces that a long standing healthcare client based in California has expanded its contract subscribing to another  (“ASR”). The client originally deployed their first K5 ASR…

Mounjaro Shows Promise in Preventing Type 2 Diabetes in Prediabetic Patients

Mounjaro, Eli Lilly's (NYSE:LLY) Type 2 diabetes medication, is demonstrating significant potential within the pharmaceutical industry. A series of successful clinical trials and robust market performance have positioned Mounjaro as a leading contender among currently available medications. Recent trial results, announced by Lilly on Tuesday, further solidify Mounjaro's promising profile,…

Mitsubishi Ralliart’s Triton Finishes in Fifth Place Overall in Asia Cross Country Rally 2024: Team Determined to Make a Comeback Next Year

TOKYO, Aug 21, 2024 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced that Team Mitsubishi Ralliart, for which the company provides technical support, has won fifth place overall in the Asia Cross Country Rally (hereafter, AXCR) 2024, held in Thailand from August 11 to 17,…

Sihuan Pharmaceutical (00460.HK): Subsidiary Huisheng Biopharmaceutical Reshapes Diabetes Treatment Landscape With Two Home-Grown Insulin Products

EQS Newswire / 21/08/2024 / 10:07 UTC+8 1. With Two Home-Grown Insulin Products Approved for Marketing, It Leads the Development of The Domestic Insulin MarketOn August 6th, Sihuan Pharmaceutical (00460.HK) announced that Insulin Degludec and Insulin Aspart Injection (trade name: Huiyoujia), developed by its subsidiary Huisheng Biopharmaceutical, was approved for…

Q2 Metals Clarifies Technical Disclosure

Vancouver, BC, Aug 21, 2024 - (ACN Newswire via SeaPRwire.com) - Q2 Metals Corp. (TSXV:QTWO)(OTCQB:QUEXF)(FSE:458) (" Q2 " or the " Company ") announces that, as a result of a technical review by the British Columbia Securities Commission, the Company is issuing the following news release to clarify its technical disclosure as it pertains to the…